News
Sichenzia Ross Ference Carmel LLP Represents Infintium Fuel Cell Systems, Inc. in a Business Combination with Goldenstone Acquisition Limited
Sichenzia Ross Ference Carmel LLP Represents Kaival Brands in a $6 Million Public Offering
Sichenzia Ross Ference Carmel LLP represents Presidio Property Trust, Inc. in Pricing of $1.74 Million Public Offering of Series D Preferred Stock
Sichenzia Ross Ference Carmel LLP Represents MGO Global in a Business Combination Agreement with Heidmar
New York, NY – June 21, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented MGO Global Inc, a digitally-native, lifestyle brand portfolio company, (“MGO”, “MGO Global”, or the “Company”) in a business combination agreement with Heidmar, Inc., a global leader in the crude oil and refined petroleum product tanker market (“Heidmar”).…
Read MoreSichenzia Ross Ference Carmel LLP Represents Sharps Technology, Inc. in $3.4 Million Reg A+ Warrant Inducement Offering
Sichenzia Ross Ference Carmel Represents Joseph Gunnar & Co., LLC in a $3 Million Private Placement for Beeline Financial Holdings Inc.
Sichenzia Ross Ference Carmel LLP Represents BioSig Technologies, Inc. in $3 Million Registered Direct Offering
Sichenzia Ross Ference Carmel LLP represents Presidio Property Trust, Inc. in Shareholder Activism Matter
Press Release – New York, NY – May 17, 2024 – Sichenzia Ross Ference Carmel LLP served as a legal advisor to Presidio Property Trust, Inc. (“Presidio” or the “Company”), an internally managed, diversified real estate investment trust, in connection with its defense against director nominations from an activist shareholder group. The Company entered into a…
Read MoreSichenzia Ross Ference Carmel LLP Represents BriaCell Therapeutics Corp. in $5 Million Registered Direct Offering
Press Release – New York, NY – May 17, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, in a $5 million registered direct offering. The Company sold an aggregate of 2,402,935 common…
Read MoreCLIENT ALERT: Employer and Employee Update on Nationwide Ban of Non-competes – “Wait and See” or “Roll The Dice”
September 4, 2024 is the day. If the courts do not issue an order prohibiting the enforcement of all or any part of the non-compete rule, it will be the law of the land starting September 4, 2024. The legal challenges have already been-fast-tracked. We expect a decision on whether the non-compete rule stands or falls, in…
Read More
